Skip to main content
Erschienen in: Osteoporosis International 8/2019

11.05.2019 | Case Report

Diffuse osteosclerosis as a presentation of recurrent breast cancer: role of endothelin 1

verfasst von: K. G. Zarnecki, J. Kristianto, J. Charlson, B. Wilson, R. D. Blank, J. L. Shaker

Erschienen in: Osteoporosis International | Ausgabe 8/2019

Einloggen, um Zugang zu erhalten

Abstract

Summary

We report a 46-yr-old woman with a history of breast cancer who presented with diffuse myalgias, bone pain, and osteosclerosis. She was found to have recurrent breast cancer producing endothelin-1.

Introduction

Acquired osteosclerosis can be caused by various disorders. Endothelin -1 is believed to contribute to osteosclerosis caused by breast cancer.

Methods

Although the bone marrow biopsy did not reveal breast cancer, she developed skin lesions consistent with metastatic breast cancer. She ultimately died from progressive disease. At autopsy immunohistochemistry for endothelin-1 was performed on a section from the L5 vertebral body.

Results

The section from the L5 vertebral body showed small foci of cells consistent with metastatic carcinoma and a prominent sclerotic response. Immunohistochemistry for endothelin-1 was strongly positive.

Conclusions

Recurrent breast cancer may present with diffuse osteosclerosis. Endothelin-1 may be a paracrine factor responsible for increased bone formation and osteosclerosis.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Rosol TJ (2000) Pathogenesis of bone metastases: role of tumor related proteins. J Bone Miner Res 15:844–850CrossRefPubMed Rosol TJ (2000) Pathogenesis of bone metastases: role of tumor related proteins. J Bone Miner Res 15:844–850CrossRefPubMed
2.
Zurück zum Zitat Eck L, Graves L III, Lukert B, Bhattacharya (2008) Sclerotic bone changes on densitometry testing in a patient with a remote history of breast cancer. Endocr Pract 14(1):125–126CrossRefPubMed Eck L, Graves L III, Lukert B, Bhattacharya (2008) Sclerotic bone changes on densitometry testing in a patient with a remote history of breast cancer. Endocr Pract 14(1):125–126CrossRefPubMed
4.
Zurück zum Zitat Achbarou A, Kaiser S, Tremblay G, Ste-Marie LG, Brodt P, Goltzman D, Rabbani SA (1994) Urokinase overproduction results in increased skeletal metastasis by prostate cancer cells in vivo. Cancer Res 54(9):2372–2377PubMed Achbarou A, Kaiser S, Tremblay G, Ste-Marie LG, Brodt P, Goltzman D, Rabbani SA (1994) Urokinase overproduction results in increased skeletal metastasis by prostate cancer cells in vivo. Cancer Res 54(9):2372–2377PubMed
5.
Zurück zum Zitat Thalmann GN, Anezinis PE, Chang SM, Zhau HE, Kim EE, Hopwood VL, Pathak S, con Eschenbach AC, Chung LW (1994) Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. Cancer Res 54:2577–2581PubMed Thalmann GN, Anezinis PE, Chang SM, Zhau HE, Kim EE, Hopwood VL, Pathak S, con Eschenbach AC, Chung LW (1994) Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. Cancer Res 54:2577–2581PubMed
6.
Zurück zum Zitat Gingrich JR, Barrios RJ, Morton RA, Boyce BF, DeMayo FJ, Finegold MJ, Angelopoulou R, Rosen JM, Greenberg NM (1996) Metastatic prostate cancer in a transgenic mouse. Cancer Res 56:4096–4102PubMed Gingrich JR, Barrios RJ, Morton RA, Boyce BF, DeMayo FJ, Finegold MJ, Angelopoulou R, Rosen JM, Greenberg NM (1996) Metastatic prostate cancer in a transgenic mouse. Cancer Res 56:4096–4102PubMed
7.
Zurück zum Zitat Nelson JB, Chan-Tach K, Hedican SP, Magnuson SR, Opgenorth TJ, , Bova GS, & Simons JW. Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate Cancer (1996) Cancer Res 56, 663–668PubMed Nelson JB, Chan-Tach K, Hedican SP, Magnuson SR, Opgenorth TJ, , Bova GS, & Simons JW. Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate Cancer (1996) Cancer Res 56, 663–668PubMed
8.
Zurück zum Zitat Nelson JB, Hedican SP, Geroge DJ, Reddi AH, Piantadosi S, Eisenberger AA, Simons JW (1995) Identification of endothelin–1 in the pathophysiology of metastatic adenocarcinoma of the prostate. Nat Med 1:944–949CrossRefPubMed Nelson JB, Hedican SP, Geroge DJ, Reddi AH, Piantadosi S, Eisenberger AA, Simons JW (1995) Identification of endothelin–1 in the pathophysiology of metastatic adenocarcinoma of the prostate. Nat Med 1:944–949CrossRefPubMed
9.
Zurück zum Zitat Nelson JB, Nguyne SH, Wu-Wong JR, Opgenorth TJ, Dixon DB, Chung LW, Inoue N (1999) New bone formation in an osteoblastic tumor model is increased by endothelin-1 overexpression and decreased by endothelin a receptor blockade. Urology 53:1063–1069CrossRefPubMed Nelson JB, Nguyne SH, Wu-Wong JR, Opgenorth TJ, Dixon DB, Chung LW, Inoue N (1999) New bone formation in an osteoblastic tumor model is increased by endothelin-1 overexpression and decreased by endothelin a receptor blockade. Urology 53:1063–1069CrossRefPubMed
12.
Zurück zum Zitat Guise TA (2003) A causual role for endothelin-1 in the pathogenesis of osteoblastic bone metastases. PNAS 100(19):10954–10959CrossRefPubMed Guise TA (2003) A causual role for endothelin-1 in the pathogenesis of osteoblastic bone metastases. PNAS 100(19):10954–10959CrossRefPubMed
13.
Zurück zum Zitat Tamkus D, Sikorskii A, Gallo K, Wiese D, Leece C, Madhukar B, Chivu S, Chitneni S, Dimitrov N (2013) Endothelin-1 enriched tumor phenotype predicts breast cancer recurrence. ISRN Oncol 2013:7 Tamkus D, Sikorskii A, Gallo K, Wiese D, Leece C, Madhukar B, Chivu S, Chitneni S, Dimitrov N (2013) Endothelin-1 enriched tumor phenotype predicts breast cancer recurrence. ISRN Oncol 2013:7
14.
Zurück zum Zitat Kedzierski RM, Yanagisawa M (2001) Endothelin system: the double-edged sword in health and disease. Annu Rev Pharmacol Toxicol 41:851–876CrossRefPubMed Kedzierski RM, Yanagisawa M (2001) Endothelin system: the double-edged sword in health and disease. Annu Rev Pharmacol Toxicol 41:851–876CrossRefPubMed
15.
Zurück zum Zitat Malek AM, Greene AL, Izumo S (1993) Regulation of endothelin 1 gene by fluid shear stress is transcriptionally mediated and independent of protein kinase C and cAMP. Proc Natl Acad Sci U S A 90:5999–6003CrossRefPubMedPubMedCentral Malek AM, Greene AL, Izumo S (1993) Regulation of endothelin 1 gene by fluid shear stress is transcriptionally mediated and independent of protein kinase C and cAMP. Proc Natl Acad Sci U S A 90:5999–6003CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, deWit D, Yanagisawa M (1994) ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell 78:473–485CrossRefPubMed Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, deWit D, Yanagisawa M (1994) ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell 78:473–485CrossRefPubMed
19.
Zurück zum Zitat Clines G, Mohammad KS, Bao Y, Stephens O, Suva L, Shaughnessy JD, Fox JW, Chirgwin J, Guise T (2007) Dickkopf homolog 1 mediates Endothelin-1-stimulated new bone formation. Mol Endocrinol 21(2):486–498CrossRefPubMed Clines G, Mohammad KS, Bao Y, Stephens O, Suva L, Shaughnessy JD, Fox JW, Chirgwin J, Guise T (2007) Dickkopf homolog 1 mediates Endothelin-1-stimulated new bone formation. Mol Endocrinol 21(2):486–498CrossRefPubMed
20.
Zurück zum Zitat Johnson MG, Kristianto J, Yuan B, Konicke K, Blank R (2014) Big endothelin changes the cellular miRNA environment in TMOb osteoblasts and increases mineralization. Connect Tissue Res 55(Suppl 1):113–116CrossRefPubMedPubMedCentral Johnson MG, Kristianto J, Yuan B, Konicke K, Blank R (2014) Big endothelin changes the cellular miRNA environment in TMOb osteoblasts and increases mineralization. Connect Tissue Res 55(Suppl 1):113–116CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Qi P, Chen M, Zhang LX, Song RX, He ZH, Wang ZP (2015) A meta-analysis and indirect comparison of endothelin a receptor antagonist for castration-resistant prostate cancer. PLoS One 10(7):e0133803CrossRefPubMedPubMedCentral Qi P, Chen M, Zhang LX, Song RX, He ZH, Wang ZP (2015) A meta-analysis and indirect comparison of endothelin a receptor antagonist for castration-resistant prostate cancer. PLoS One 10(7):e0133803CrossRefPubMedPubMedCentral
Metadaten
Titel
Diffuse osteosclerosis as a presentation of recurrent breast cancer: role of endothelin 1
verfasst von
K. G. Zarnecki
J. Kristianto
J. Charlson
B. Wilson
R. D. Blank
J. L. Shaker
Publikationsdatum
11.05.2019
Verlag
Springer London
Erschienen in
Osteoporosis International / Ausgabe 8/2019
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-019-04998-5

Weitere Artikel der Ausgabe 8/2019

Osteoporosis International 8/2019 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.